GSK2636771 (Standard)
GSK2636771 (Standard) is the analytical standard of GSK2636771. This product is intended for research and analytical applications. GSK2636771 is a potent, selective and orally bioavailable inhibitor of PI3Kβ with a Ki of 0.89 nM and an IC50 of 5.2 nM, showing 900-fold selectivity over p110α and p110γ, and 10-fold selectivity over p110δ isoforms.
Product Specifications
CAS Number
1372540-25-4
UNSPSC
12352100
Target
PI3K; Reference Standards
Related Pathways
Others; PI3K/Akt/mTOR
Field of Research
Cancer
Smiles
CC1=NC2=C(C(O)=O)C=C(C=C2N1CC3=CC=CC(C(F)(F)F)=C3C)N4CCOCC4
Molecular Formula
C22H22F3N3O3
Molecular Weight
433.42
References & Citations
[1]Weigelt B, et al. PI3K pathway dependencies in endometrioid endometrial cancer cell lines. Clin Cancer Res. 2013, 19 (13), 3533-3544.|[2]Hosford SR, et al. Combined inhibition of both p110α and p110β isoforms of phosphatidylinositol 3-kinase is required for sustained therapeutic effect in PTEN-deficient, ER+ breast cancer. Clin Cancer Res. 2016 Nov 30
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM2391-50 1x 50 µL
GAD1 / GAD67 (GABAergic Neuronal Marker) (GAD1/2391), 1mg/mL
Sign In for Pricing
View Details 
LY421958 100 µg
ALDH1L2 (NM_001034173) Human Over-expression Lysate
Sign In for Pricing
View Details 
